RenovoRx Inc RNXT Q1 2026 Earnings Wider Loss Per Share Amid PreRevenue ClinicalStage Operations aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development STEL Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Linde Q1 2026 Earnings EPS Beats Estimates as Margin Focus Drives Slight Stock Uptick REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs HCWC Q4 2025 Earnings Narrow EPS Beat Masks Operational Uncertainty Shares Slip